Disruption of NANOG-driven epithelial-mesenchymal transition (EMT) and self-renewal restores drug sensitivity in colorectal cancer
Drug Resistance Updates · 2026
DOI: 10.1016/j.drup.2025.101321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Kiarash Saleki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genetics & Stem Cell Group, The BioDiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK; Research Center …. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Colorectal Neoplasms, Nanog Homeobox Protein, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI Medical Research Council, University of Nottingham, King Saud University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Genetics & Stem Cell Group, The BioDiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University o…
- Cancer Genetics & Stem Cell Group, The BioDiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK; Department of Anatomy and Stem Cell Unit, College of Medicine, King Saud University, P…
- Cancer Genetics & Stem Cell Group, The BioDiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
- Cancer Genetics & Stem Cell Group, The BioDiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK; Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
- Cancer Genetics & Stem Cell Group, The BioDiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK; Department of Molecular Oncology, H. Lee Moffitt Cancer Centre & Research Institute, T…
- Cancer Genetics & Stem Cell Group, The BioDiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK; Department of Surgery and Cancer, Imperial College London, London, UK.
Förderung
- UKRI Medical Research Council
- University of Nottingham
- King Saud University
- Cancer Research UK
Zitieren
APA
Saleki, K., Shaheen, S., Xue, M., Mazloomi, A., Youssefi, S., Kashfi, H., Ahmed, M., Babaei-Jadidi, R., Spencer-Dene, B., Bonnet, D., Denning, C., & Nateri, A. S. (2026). Disruption of NANOG-driven epithelial-mesenchymal transition (EMT) and self-renewal restores drug sensitivity in colorectal cancer. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2025.101321
Vancouver
Saleki K, Shaheen S, Xue M, Mazloomi A, Youssefi S, Kashfi H, et al. Disruption of NANOG-driven epithelial-mesenchymal transition (EMT) and self-renewal restores drug sensitivity in colorectal cancer. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2025.101321
BibTeX
@article{Saleki2026,
author = {Saleki, Kiarash and Shaheen, Sameerah and Xue, Miao and Mazloomi, Amirreza and Youssefi, Sepideh and Kashfi, Hossein and Ahmed, Mehreen and Babaei-Jadidi, Roya and Spencer-Dene, Bradley and Bonnet, Dominique and Denning, Chris and Nateri, Abdolrahman S},
title = {Disruption of NANOG-driven epithelial-mesenchymal transition (EMT) and self-renewal restores drug sensitivity in colorectal cancer},
journal = {Drug Resistance Updates},
year = {2026},
doi = {10.1016/j.drup.2025.101321}
}
EUVIMED